Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2532 of 6351
-
New study settles debate: surgery or PT for torn rotator cuff?
Disease control CompletedRotator cuff tears are one of the most common reasons to seek musculoskeletal care in the United States and one of the fastest growing ambulatory surgery procedures. However, data on comparison of operative versus non-operative treatment is lacking and urgently needed.
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can your own stem cells reverse frailty? suspended trial holds clues
Disease control PausedWith increasing age and health issues associated with aging, many systemic cellular and structural changes are known to occur. The intent of this trial is to determine the safety and efficacy of delivery of autologous cellular stromal vascular fraction (cSVF) to improve the quali…
Sponsor: Healeon Medical Inc • Aim: Disease control
Last updated Jun 26, 2026 16:07 UTC
-
New lifestyle program aims to slash heart risks in south asians
Disease control CompletedResearch show that South Asians (SA) have a high burden of Cardiovascular Disease (CVD) risk factors of which, poor diet and physical inactivity remain the major lifestyle risk factors in SA. Intensive diet and physical activity behavioral interventions have been shown to yield i…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Acupuncture may ease chronic pain in spinal cord injury
Symptom relief CompletedOf the more than 250,000 Americans with severe spinal cord injury (SCI), 42,000 are military veterans. The Department of Veterans Affairs is the largest single network of SCI care providers in the nation. Patients with SCI experience functional disabilities as well as chronic pai…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Microtransplant without immune drugs shows promise for leukemia patients too sick for standard transplant
Disease control CompletedThis study aims at evaluating the safety of an approach based on HLA-mismatched Microtransplantation without immunosuppressive treatment in patients With myeloid hemopathies who are ineligible to conventional allograft
Phase 1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Ebola vaccine in a nasal spray? early trial halted
Vaccine Stopped earlyThe purpose of this study is to evaluate the safety, infectivity, and immunogenicity of two doses of the HPIV3/ΔHNF/EbovZ GP vaccine candidate when administered intranasally in healthy adults.
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 11:03 UTC
-
Can acupuncture help when pain pills fail? new study tests ancient remedy for spine disease
Symptom relief OngoingA pragmatic, prospective, randomized controlled trial will be conducted in patients with axial spondyloarthritis who are NSAID inadequate responders. Patients will be randomized in a 1:1 ratio to either receive standard rheumatological care or a Traditional Chinese Medicine physi…
Sponsor: Singapore General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Shorter antibiotic course may be just as effective for tough lung infections
Disease control CompletedThere is evidence that using shorter antibiotic regimens may help in decreasing antimicrobial resistance and reducing drug-related adverse events.6 Moreover, short-course treatments were found to be as effective as longer-course antibiotic treatment.7,8 In a pooled analysis of fo…
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Promising Crohn's drug trial halted early – what happened?
Disease control Stopped earlyThis is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Thousands enrolled in supraflex stent registry for coronary artery disease
Disease control Recruiting nowThe primary objective of this registry is to evaluate the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Bladder cancer combo therapy trial cut short – what we know
Disease control Stopped earlyThis study will assess efficacy (based on response rate) and safety (based on grade ≥ 3 severe adverse effects) of the combination Gemcitabine Cisplatin (GC) + anti-PD-L1 (avelumab) in first-line treatment for locally advanced or metastatic urothelial bladder cancer patients, aft…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Cooler or warmer? new trial tests best temperature for aortic surgery safety
Disease control Recruiting nowHypothermic circulatory arrest is an important surgical technique, allowing complex aortic surgeries to be performed safely. Hypothermic circulatory arrest provides protection to cerebral and visceral organs, but may result in longer cardiopulmonary bypass times during surgery, i…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug shows promise for lupus and kidney complications
Disease control CompletedThis was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).
Phase 1/2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New prostate cancer combo trial ends early
Disease control Stopped earlyThis study consists of a dose escalation study with an expansion phase to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and preliminary efficacy of exicorilant (CORT125281) in combination with enzalutamide in patients with metastatic castrat…
Phase 1/2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New anemia pill challenges standard shot for dialysis patients
Disease control CompletedFor hemodialysis subjects currently receiving ESAs with anemia associated with chronic kidney disease, demonstrate non-inferiority of MT-6548 compared to darbepoetin alfa using Hb value and evaluate long-term safety of MT-6548.
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New vaginal ring aims to give women more birth control choices
Disease control CompletedThis will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® an…
Phase 2 • Sponsor: Premier Research • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New methods could spot hidden heart artery disease sooner after transplant
Knowledge-focused OngoingHeart transplantation is an effective life-saving treatment for patients with end-stage heart disease. After a transplant, the new heart may develop narrowing in the arteries, causing heart failure, heart attacks and abnormal heart rhythms. This condition is known as cardiac allo…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Could a seizure drug soothe IBS belly pain?
Symptom relief CompletedAbdominal pain remains the most deleterious symptom for patients with irritable bowel syndrome (IBS) and is causing a significant alteration of their quality of life. The visceral hypersensitivity seems to be one of the key mechanisms that could explain the abdominal pain in thes…
Phase 2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Head-to-Head: which drug works best for sudden joint pain in seniors?
Symptom relief CompletedChondrocalcinosis, recently renamed the calcium pyrophosphate deposition (CPPD) disease, is a very frequent affection of the elderly and causes very painful arthritis. International recommendations for the treatment of patients suffering from CPPD are based upon rare studies, no…
Phase 3 • Sponsor: Lille Catholic University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
When to transfuse? study tests best blood strategy for heart patients after surgery
Disease control CompletedThe goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC